Treatment of the photo-oculodynia syndrome with botulinum toxin A

Neuro-Ophthalmology

Volumn 31, Issue 4, 2007, Pages 105-109

  Shoari, Mohammad ^a   Katz, Bradley J ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin type A; Ocular pain; Ocular trauma; Photo oculodynia syndrome; Photosensitivity

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; DESIPRAMINE; ELETRIPTAN; GABAPENTIN; HYDROCODONE; IBUPROFEN; INDOMETACIN; MIRTAZAPINE; NAPROXEN; OXCARBAZEPINE; PARACETAMOL; TOPIRAMATE; TRAZODONE; VALDECOXIB; VERAPAMIL; ZONISAMIDE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EYE PAIN; HUMAN; MALE; MIGRAINE; NERVE BLOCK; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOTO OCULODYNIA SYNDROME; PHOTOSENSITIVITY; TREATMENT RESPONSE;

EID: 34547937941     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.1080/01658100701389802     Document Type: Article

References (25)

1. Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15:90-94.
2. Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: Mechanisms of action. Arq Neuropsiquiatr. 2005;63:180-185.
3. Elston JS. The use of botulinum toxin A in the treatment of strabismus. Trans Ophthalmol Soc U K. 1985;104 (Pt 2):208-210.
4. Lennerstrand G, Nordbo OA, Tian S, Tian S, Eriksson-Derouet B, Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76:27-7.
5. Chang LB, Tsai CP, Liao KK, et al. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm. Zhonghua Yi Xue Za Zhi (Taipei) 1999;62:1-5.
6. Jost WH, Kohl A. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol. 2001;248 (Suppl 1):21-24.
7. Price J, Farish S, Taylor H, O'Day J. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology. 1997;104:865-868.
8. Price J, O'Day J. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust N Z J Ophthalmol. 1994;22:255-260.
9. Park YC, Lim JK, Lee DK, Yi SD. Botulinum A toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci. 1993;8:334-340.
10. Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie. 2000;82:943-953.
11. Rubenstein EJ. Botulinum toxin for headache. Int Ophthalmol Clin. 2005;45:93-97.
12. Argoff CE. The use of botulinum toxins for chronic pain and headaches. Curr Treat Options Neurol. 2003;5:483-492.
13. Guyuron B, Tucker T, Davis J. Surgical treatment of migraine headaches. Plast Reconstr Surg. 2002;109:2183-2189.
14. Guyuron B, Kriegler JS, Davis J, et al. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005;115:1-9.
15. Kramer HH, Angerer C, Erbguth F, Schmelz M, Birklein F. Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol. 2003;250:188-193.
16. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003;43 (Suppl 1):S9-15.
17. Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain J Pain. 2002;3:21-27.
18. Acquadro MA, Borodic GE. Botulinum toxin efficacy for the treatment of pain. J Clin Anesth. 2005;17:328-330.
19. Klein AW. The therapeutic potential of botulinum toxin. Dermatol Surg. 2004;30:452-455.
20. Tarsy D, Sudarsky L, Charness ME. Limb dystonia following electrical injury. Mov Disord. 1994;9:230-232.
21. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S177-81.
22. Liu HT, Tsai SK, Kao MC, Hu JS. Botulinum toxin a relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med. 2006 Jan-Feb;7(1):89-91.
23. Mulleners WM, Aurora SK, Chronicle EP, Stewart R, Gopal S, Koehler PJ. Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately. Headache. 2001 Jan;41(1):31-9.
24. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - Current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70.
25. Rosenblatt MA, Sakol PJ. Ocular and periocular pain. Otolaryngol Clin North Am. 1989 Dec;22(6):1173-203.